Skip to main content
. Author manuscript; available in PMC: 2019 Aug 20.
Published in final edited form as: ACS Biomater Sci Eng. 2018 Jul 23;4(9):3374–3383. doi: 10.1021/acsbiomaterials.8b00803

Figure 3.

Figure 3.

Expression of Brn3a in retinal cross sections following ONC and Sul–PSHU–PNIPAAm intravitreal treatment after 2 weeks (A) when compared to a healthy eye receiving no ONC and no treatment (B). There was no significant difference observed between these two groups (C). Blue staining indicates DAPI. Red staining indicates Brn3a expression. Scale bar = 50 μm.